Blood Proteins FGF2 and PRDX3 Fail to Improve Long COVID Prediction Across Cohorts
A rigorous cross-cohort analysis finds that the blood proteins FGF2 and PRDX3, measured during acute COVID-19, do not reliably improve ...
A rigorous cross-cohort analysis finds that the blood proteins FGF2 and PRDX3, measured during acute COVID-19, do not reliably improve ...
A new Journal of General Internal Medicine review gives primary care clinicians a pragmatic framework for diagnosing and managing Long ...
A comprehensive new review in the Journal of Translational Medicine synthesizes the epidemiology, biology, and treatment controversies of ME/CFS, highlighting ...
A randomized phase 2a trial found the SARS-CoV-2 monoclonal antibody AER002 safe but ineffective for Long COVID overall, though post-hoc ...
Eric and Wendy Schmidt have launched Schmidt Global Health, a nonprofit expanding their Long Covid initiative into a worldwide effort ...
Johns Hopkins researchers defend their external clinical validation of the RECOVER Long COVID index, arguing their specialty-clinic study complements rather ...
A large Belgian survey of primary care patients aged 45 and older finds that Long COVID affects about one in ...
A triple-blind randomized trial found that an SPM-enriched supplement added no benefit over placebo for long COVID patients undergoing telerehabilitation, ...
A Brazilian case-control study finds that adults with long COVID show persistent endothelial dysfunction and reduced aerobic capacity three years ...
A Swedish register study of over 1.3 million matched individuals found that a fourth COVID-19 vaccine dose reduced the risk ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine